• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠肺炎老年患者与肺栓塞临床量表及D-二聚体的准确性:OCTA-COVID研究

Elderly Population with COVID-19 and the Accuracy of Clinical Scales and D-Dimer for Pulmonary Embolism: The OCTA-COVID Study.

作者信息

Quezada-Feijoo Maribel, Ramos Mónica, Lozano-Montoya Isabel, Sarró Mónica, Cabo Muiños Verónica, Ayala Rocío, Gómez-Pavón Francisco J, Toro Rocío

机构信息

Cardiology Departament, Hospital Central de la Cruz Roja, C/Reina Victoria, 24, 28003 Madrid, Spain.

Facultad de Medicina, Universidad Alfonso X El Sabio, Avda. De la Universidad, 1, Villanueva de la Cañada, 28691 Madrid, Spain.

出版信息

J Clin Med. 2021 Nov 20;10(22):5433. doi: 10.3390/jcm10225433.

DOI:10.3390/jcm10225433
PMID:34830715
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8619636/
Abstract

BACKGROUND

Elderly COVID-19 patients have a high risk of pulmonary embolism (PE), but factors that predict PE are unknown in this population. This study assessed the Wells and revised Geneva scoring systems as predictors of PE and their relationships with D-dimer (DD) in this population.

METHODS

This was a longitudinal, observational study that included patients ≥75 years old with COVID-19 and suspected PE. The performances of the Wells score, revised Geneva score and DD levels were assessed. The combinations of the DD level and the clinical scales were evaluated using positive rules for higher specificity.

RESULTS

Among 305 patients included in the OCTA-COVID study cohort, 50 had suspected PE based on computed tomography pulmonary arteriography (CTPA), and the prevalence was 5.6%. The frequencies of PE in the low-, intermediate- and high-probability categories were 5.9%, 88.2% and 5.9% for the Geneva model and 35.3%, 58.8% and 5.9% for the Wells model, respectively. The DD median was higher in the PE group (4.33 mg/L; interquartile range (IQR) 2.40-7.17) than in the no PE group (1.39 mg/L; IQR 1.01-2.75) ( < 0.001). The area under the curve (AUC) for DD was 0.789 (0.652-0.927). After changing the cutoff point for DD to 4.33 mg/L, the specificity increased from 42.5% to 93.9%.

CONCLUSIONS

The cutoff point DD > 4.33 mg/L has an increased specificity, which can discriminate false positives. The addition of the DD and the clinical probability scales increases the specificity and negative predictive value, which helps to avoid unnecessary invasive tests in this population.

摘要

背景

老年新冠肺炎患者发生肺栓塞(PE)的风险较高,但该人群中预测PE的因素尚不清楚。本研究评估了Wells评分和修订的Geneva评分系统作为该人群中PE的预测指标及其与D-二聚体(DD)的关系。

方法

这是一项纵向观察性研究,纳入了年龄≥75岁的新冠肺炎合并疑似PE患者。评估了Wells评分、修订的Geneva评分和DD水平的表现。使用提高特异性的阳性规则评估DD水平与临床量表的组合。

结果

在OCTA-COVID研究队列纳入的305例患者中,50例基于计算机断层扫描肺动脉造影(CTPA)疑似PE,患病率为5.6%。Geneva模型中低、中、高概率类别中PE的频率分别为5.9%、88.2%和5.9%,Wells模型中分别为35.3%、58.8%和5.9%。PE组的DD中位数(4.33 mg/L;四分位间距(IQR)2.40-7.17)高于无PE组(1.39 mg/L;IQR 1.01-2.75)(<0.001)。DD的曲线下面积(AUC)为0.789(0.652-0.927)。将DD的截断点改为4.33 mg/L后,特异性从42.5%提高到93.9%。

结论

截断点DD>4.33 mg/L时特异性增加,可区分假阳性。DD与临床概率量表的联合使用提高了特异性和阴性预测值,有助于避免对该人群进行不必要的侵入性检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaf/8619636/c2251db45f16/jcm-10-05433-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaf/8619636/0556053b1671/jcm-10-05433-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaf/8619636/50148fd77d46/jcm-10-05433-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaf/8619636/ee83bb6d2646/jcm-10-05433-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaf/8619636/c2251db45f16/jcm-10-05433-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaf/8619636/0556053b1671/jcm-10-05433-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaf/8619636/50148fd77d46/jcm-10-05433-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaf/8619636/ee83bb6d2646/jcm-10-05433-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaf/8619636/c2251db45f16/jcm-10-05433-g004.jpg

相似文献

1
Elderly Population with COVID-19 and the Accuracy of Clinical Scales and D-Dimer for Pulmonary Embolism: The OCTA-COVID Study.新冠肺炎老年患者与肺栓塞临床量表及D-二聚体的准确性:OCTA-COVID研究
J Clin Med. 2021 Nov 20;10(22):5433. doi: 10.3390/jcm10225433.
2
Values of the Wells and revised Geneva scores combined with D-dimer in diagnosing elderly pulmonary embolism patients.Wells评分和修订的Geneva评分联合D-二聚体在老年肺栓塞患者诊断中的价值。
Chin Med J (Engl). 2015 Apr 20;128(8):1052-7. doi: 10.4103/0366-6999.155085.
3
A higher D-dimer threshold for predicting pulmonary embolism in patients with COVID-19: a retrospective study.用于预测新型冠状病毒肺炎患者肺栓塞的更高D-二聚体阈值:一项回顾性研究
Emerg Radiol. 2020 Dec;27(6):679-689. doi: 10.1007/s10140-020-01859-1. Epub 2020 Oct 6.
4
The Legend score synthesizes Wells, PERC, Geneva, D-dimer and predicts acute pulmonary embolism prior to imaging tests.传奇评分综合了韦尔斯评分、PERC评分、日内瓦评分、D-二聚体,并在影像学检查之前预测急性肺栓塞。
Pulmonology. 2025 Dec 31;31(1):2416828. doi: 10.1016/j.pulmoe.2023.10.002. Epub 2024 Oct 24.
5
Wells and Geneva Scores Are Not Reliable Predictors of Pulmonary Embolism in Critically Ill Patients: A Retrospective Study.危重症患者 Wells 和 Geneva 评分不能可靠预测肺栓塞:一项回顾性研究。
J Intensive Care Med. 2020 Oct;35(10):1112-1117. doi: 10.1177/0885066618816280. Epub 2018 Dec 16.
6
Predictive Model for Pulmonary Embolism in Patients with Deep Vein Thrombosis.深静脉血栓形成患者肺栓塞的预测模型
Ann Vasc Surg. 2020 Jul;66:334-343. doi: 10.1016/j.avsg.2019.12.008. Epub 2020 Jan 3.
7
Strategies to safely rule out pulmonary embolism in COVID-19 outpatients: a multicenter retrospective study.COVID-19 门诊患者中安全排除肺栓塞的策略:一项多中心回顾性研究。
Eur Radiol. 2023 Aug;33(8):5540-5548. doi: 10.1007/s00330-023-09475-6. Epub 2023 Feb 24.
8
Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.年龄校正 D-二聚体界值排除肺栓塞:ADJUST-PE 研究。
JAMA. 2014 Mar 19;311(11):1117-24. doi: 10.1001/jama.2014.2135.
9
Are the Wells Score and the Revised Geneva Score valuable for the diagnosis of pulmonary embolism in pregnancy?Wells评分和修订的Geneva评分对妊娠期肺栓塞的诊断有价值吗?
Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:166-171. doi: 10.1016/j.ejogrb.2017.12.049. Epub 2017 Dec 28.
10
Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism.用于评估肺栓塞临床可能性的修订版日内瓦评分与Wells规则的比较。
J Thromb Haemost. 2008 Jan;6(1):40-4. doi: 10.1111/j.1538-7836.2007.02820.x. Epub 2007 Oct 29.

引用本文的文献

1
Analysis of the functioning of temporary dialysis catheters in patients with COVID-19.新型冠状病毒肺炎患者临时透析导管功能分析
J Vasc Bras. 2025 Jul 28;24:e20250005. doi: 10.1590/1677-5449.202500052. eCollection 2025.
2
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach.重症 COVID-19 患者体内靶向心磷脂和血小板糖蛋白的自身抗体水平随年龄升高:一种系统生物学方法
NPJ Aging. 2023 Aug 24;9(1):21. doi: 10.1038/s41514-023-00118-0.
3
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup.

本文引用的文献

1
Predictive Factors of Pulmonary Embolism in Older Patients with SARS-CoV-2: The OCTA-COVID-19 Study.老年2019冠状病毒病患者肺栓塞的预测因素:OCTA-COVID-19研究
J Clin Med. 2021 Jul 5;10(13):2998. doi: 10.3390/jcm10132998.
2
Cardiac biomarkers in patients with COVID-19: pragmatic tools in hard times.新型冠状病毒肺炎患者的心脏生物标志物:艰难时期的实用工具
Rev Esp Cardiol (Engl Ed). 2021 Jul;74(7):566-568. doi: 10.1016/j.rec.2021.01.006. Epub 2021 Jan 21.
3
Atypical symptoms of COVID-19 in hospitalised oldest old adults.住院高龄老年人新型冠状病毒肺炎的非典型症状
Sepsis 相关的急性肾损伤:第 28 次急性疾病质量倡议工作组的共识报告。
Nat Rev Nephrol. 2023 Jun;19(6):401-417. doi: 10.1038/s41581-023-00683-3. Epub 2023 Feb 23.
4
Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98.凝血参数可通过神经网络预测 COVID-19 相关血栓,阳性预测值为 98%。
Front Immunol. 2022 Sep 28;13:977443. doi: 10.3389/fimmu.2022.977443. eCollection 2022.
5
Special Issue "COVID-19 and Venous Thromboembolism".特刊“COVID-19与静脉血栓栓塞症”。
J Clin Med. 2022 Jul 1;11(13):3822. doi: 10.3390/jcm11133822.
Rev Esp Geriatr Gerontol. 2021 Mar-Apr;56(2):120-121. doi: 10.1016/j.regg.2020.11.001. Epub 2020 Dec 10.
4
Wells Score to Predict Pulmonary Embolism in Patients with Coronavirus Disease 2019.Wells 评分预测 2019 冠状病毒病患者的肺栓塞。
Am J Med. 2021 May;134(5):688-690. doi: 10.1016/j.amjmed.2020.10.044. Epub 2020 Dec 11.
5
Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retrospective Study by the COVIDIC Initiative in a Swiss University Hospital.预测 COVID-19 住院患者的静脉血栓栓塞事件:瑞士大学医院 COVIDIC 计划的观察性回顾性研究。
Biomed Res Int. 2020 Nov 6;2020:9126148. doi: 10.1155/2020/9126148. eCollection 2020.
6
COVID-19 and Hypercoagulability: A Review.新型冠状病毒肺炎与高凝状态:综述
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620962853. doi: 10.1177/1076029620962853.
7
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.美国血液学会2020年静脉血栓栓塞管理指南:深静脉血栓形成和肺栓塞的治疗
Blood Adv. 2020 Oct 13;4(19):4693-4738. doi: 10.1182/bloodadvances.2020001830.
8
Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis.非危重症 COVID-19 患者肺栓塞的发生率。具有挑战性诊断的预测因素。
J Thromb Thrombolysis. 2021 Jan;51(1):40-46. doi: 10.1007/s11239-020-02190-9.
9
Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.新型冠状病毒病患者的肺栓塞与 d-二聚体水平升高。
Emerg Infect Dis. 2020 Aug;26(8):1941-1943. doi: 10.3201/eid2608.201477. Epub 2020 Apr 29.
10
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会(ISTH)关于新冠病毒病(COVID-19)凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.